TW200529864A - Method for producing maca extract - Google Patents
Method for producing maca extract Download PDFInfo
- Publication number
- TW200529864A TW200529864A TW094102402A TW94102402A TW200529864A TW 200529864 A TW200529864 A TW 200529864A TW 094102402 A TW094102402 A TW 094102402A TW 94102402 A TW94102402 A TW 94102402A TW 200529864 A TW200529864 A TW 200529864A
- Authority
- TW
- Taiwan
- Prior art keywords
- maca
- extract
- patent application
- scope
- maca extract
- Prior art date
Links
- 235000000421 Lepidium meyenii Nutrition 0.000 title claims abstract description 106
- 235000012902 lepidium meyenii Nutrition 0.000 title claims abstract description 106
- 240000000759 Lepidium meyenii Species 0.000 title claims abstract description 105
- 239000000284 extract Substances 0.000 title claims abstract description 102
- 238000004519 manufacturing process Methods 0.000 title description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 96
- 238000000605 extraction Methods 0.000 claims abstract description 56
- 235000013305 food Nutrition 0.000 claims abstract description 33
- 230000003266 anti-allergic effect Effects 0.000 claims abstract description 29
- 239000002537 cosmetic Substances 0.000 claims abstract description 21
- 239000007864 aqueous solution Substances 0.000 claims abstract description 13
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 28
- 239000000654 additive Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000009508 confectionery Nutrition 0.000 claims description 6
- 229940112822 chewing gum Drugs 0.000 claims description 5
- 235000015218 chewing gum Nutrition 0.000 claims description 5
- 238000013329 compounding Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 1
- 238000010586 diagram Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 13
- 235000013361 beverage Nutrition 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 28
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- 239000002904 solvent Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- -1 glycerol fatty acid ester Chemical class 0.000 description 12
- 229960001340 histamine Drugs 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 10
- 239000002304 perfume Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 235000013599 spices Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 235000013353 coffee beverage Nutrition 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- 210000003630 histaminocyte Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000000043 antiallergic agent Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000013409 condiments Nutrition 0.000 description 3
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- 235000019699 ravioli Nutrition 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 101100279438 Caenorhabditis elegans egg-3 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- PBWHIVNNEMWUKP-UHFFFAOYSA-N [Na].CC(O)CO.OCC(O)CO Chemical compound [Na].CC(O)CO.OCC(O)CO PBWHIVNNEMWUKP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-O benzylaminium Chemical compound [NH3+]CC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-O 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- MGDNLGRMXPBCOR-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;dodecanoate Chemical compound OCCNCCO.CCCCCCCCCCCC(O)=O MGDNLGRMXPBCOR-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020028 corn beer Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
- A23C9/1544—Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/06—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
200529864 九、發明說明: 【發明所屬之技術領域】 本發明爲有關得自十字花科植物之馬卡萃取物之萃耳又 方法,及含有該萃取物之有抗過敏作用之飮食品、香粧品或 醫藥品。 【先前技術】 以往有種種具有藥理活性之許多化合物被合成,而找出 對各種疾病有效並適用之醫藥,而在臨床使用。其中,有關 抗過敏劑有曲尼司特(tranist)、色甘酸(cromoglicic acid)鈉 (以下有時略稱「DSCG」)等化學合成醫藥品之登場,又 有作爲使從花生四烯酸生成白三烯之5 -脂加氧酶之抑制 劑,使用含多量咖啡酸之艾草萃取物等之植物萃取物。 但抗過敏劑一般多發現欲睡、口渴、胃腸障害等副作 用,長期服用之安全性成問題。他方面,有助施過敏性疾病 之治療之食品素材也有多數探索,例如已知甜茶之萃取物有 抗過敏活性(專利文獻1),含有甜茶萃取物之喉糖等之登 場,爲緩和花粉症狀而飲用。 但馬卡(Lepidium meyenii Walp)爲以南美秘魯之安第 斯高地爲原産之十字花科植物。馬卡乃匐地展葉來生長,其 根呈大頭菜之形狀。馬卡在安第斯地方約從2千年以上之前 就有栽培,當作維持健康之食品食用之植物。馬卡之主成分 爲多糖類、蛋白質等,又含許多胺基酸,尤其含有在體內不 能合成’必須從食品攝取之許多必須胺基酸。比外’豊虽地 含有各種維生素(維生素B群、C、E等)及礦物質(鈣、 200529864 % 霣 鐵、鋅等)等,在秘魯,使用馬卡之食品有數十項目。其中, 有加入馬卡之餅干及果汁「CHICHA DE MACA」、馬卡酒之 外,將馬卡之粉末撒在優格來食用等,係當作健康維持用之 食品受許多愛用之植物。 關於馬卡之效能,自古有活力再生、滋養強壯之效果, 又有抗癌作用及性機能改善作用之組成物之揭示(專利文獻 2 )。又有揭示與鹿角(antler )組合使用,則有増加人中之 睪酮濃度之效果之組成物(專利文獻3 )。更有可期待馬卡 • 之抗炎症作用及當作抗過敏劑之可能性之報告(非專利文獻 4 )。 【專利文獻1】 特開平6-192 114號公報 【專利文獻2】 美國專利第6267995 B 1公報 【專利文獻3】 特表2003-523945號公報 【非專利文獻1】醫學與生物學:Vol.145,Νο·6, ρ81-86,2002.12.10 最近,馬卡之種種效能受注目,有使用馬卡之乾燥粉碎 鲁物或萃取物之飲食品登場。但特別著眼於抗過敏作用,而將 具有強力抗過敏作用之馬卡之萃取物以安全性高之溶劑有 效萃取之方法則殆無檢討爲現狀。 【發明內容】 【發明欲解決之課題】 故本發明之課題爲可長期攝取且安全性優異之具有抗 過敏作用之馬卡萃取物之有效萃取方法,更以所得萃取物之 有抗過敏作用之飲食品,香粧品或醫藥品。 -6- 200529864 ί , 本發明者爲解決上述課題,反復致力硏究之結果,驚奇 地發現依馬卡萃取時之條件,所得萃取物之抗過敏作用之強 度大不同,尤其,萃取溶劑採用含有乙醇之水溶液時,將萃 取液之乙醇濃度及萃取溶劑之溫度限定在特定之範圍,則可 得抗過敏作用之優異萃取物,終於完成本發明。 【解決課題之手段】 故本發明提供= (1 ) 馬卡之粉碎物加含有乙醇之水溶液來萃取之馬 Φ 卡萃取物之萃取方法中,萃取液之溫度爲2〇〜75 °c爲特徵之 馬卡萃取物之萃取方法; (2) 以含有乙醇之水溶液中乙醇之濃度爲20〜100 容量%爲特徵之上述(1)之萃取方法; (3 ) 對馬卡粉碎物1重量份,含有乙醇之水溶液使 用0.3〜500重量份爲特徵之上述(1)之萃取方法; (4) 馬卡之粉碎物爲水萃取殘渣爲特徵之上述(1) 〜(3 )之萃取方法; • 又本發明提供: (5 ) 由上述(1 )〜(4 )之任一項之方法所得之馬 卡萃取物; (6 ) 含有上述(5 )之馬卡萃取物之飮食品、香粧品 或醫藥品; (7 ) 將上述(5 )之馬卡萃取物,依乾燥重量換算含 有0.01〜99.5%之上述(6)之飲食品、香粧品或醫藥品; (8) 具有抗過敏作用之上述(6)或(7)之飮食品、 -7 - 200529864 4 » 香粧品或醫藥品; (9 ) 以含有上述(5 )之馬卡萃取物爲特徵之飮食品 用、香粧品用或醫藥品用之添加劑或配合劑; (10) 係糖果、舌片、口香糖、顆粒或錠劑之上述(8) 之飮食品、香粧品或醫藥品。 【發明之效果】 本發明提供具有強力抗過敏作用,適合經口服用之馬卡 萃取物。更由含有該馬卡萃取物或其乾燥品而提供具有抗過 ® 敏作用之飮食品、香粧品或醫藥品,又提供爲製造彼等飮食 品、香粧品或醫藥品所使用之添加劑或配合劑。 【實施發明之最佳形態】 由本發明方法取得萃取物之原料所用之馬卡(Lepidium meyenii Walp )爲在南美之高地自生或栽培之十字花科植 物。萃取之原料所用部位可爲全草、花、果實、種子、包括 地下莖之莖、球根等之任何部位,尤宜用其球根部。此等原 料可由粉碎〜切斷,作成小片狀或粉狀之粉碎品來供萃取。 ® 必要時予以乾燥處理。也可用事前以水萃取之馬卡。 取得馬卡之萃取物所用萃取溶劑可爲種種溶劑,若考慮 萃取物最後配合在飲食品等而經口攝取,則由安全性而言, 宜用水-乙醇之混合水溶液(含有乙醇之水溶液)。 本發明者檢討之結果,得知當作萃取溶劑所用之含有乙 醇之水溶液乃依乙醇之含有比率而所得萃取物之抗過敏作 用之強度大不同。故此時之乙醇與水之混合比率,必須作成 可得抗過敏作用強之萃取物之混合比,具體而言,依容積 -8 - 200529864 f h 比、乙醇爲20〜100%,尤宜45〜100%之程度。 至於萃取時之萃取溶劑之溫度條件,必須作成可得抗過 敏作用強之萃取物之溫度,又由操作上而言,宜比溶劑之沸 點爲低溫度。具體而言,萃取時之萃取溶劑之溫度爲20〜 75°C,尤宜40〜60°C之程度。 萃取時之馬卡與溶劑之混合比率無特限,對馬卡1重量 份宜用溶劑0.3〜5000重量倍之程度,尤其由萃取操作,萃 取效率而言,宜5〜100重量倍。 ® 萃取時間無特限。往例也有需要數日〜數週以上來萃取 之例,但若用基於本發明之特定之乙醇含有率之萃取溶劑, 特定之範圍之萃取溫度,則1分〜7 2小時之範圍,尤其1 0 分〜5小時程度之萃取時間就足。 萃取溶劑採用水(室溫、熱水)所得之萃取物幾無抗過 敏作用。故以乙醇水溶液施行萃取操作之前,作爲前處理, 宜施行使用水之萃取操作,來除去無抗過敏活性之不純物。 所得馬卡萃取物可以就此萃取操作完了之萃取液,或除 ® 去萃取液之溶劑之濃縮物,或將萃取液依凍乾或風乾等手段 乾燥所得之乾燥粉末品使用。由保存安定性及携帯容易而 言,宜用萃取濃縮物或乾燥粉末品。本發明所謂馬卡萃取物 乃指此等萃取液、萃取濃縮物及乾燥粉末品。 本發明提供含有此等所得馬卡萃取物之飮食品、香粧品 及醫藥品等。馬卡本身爲自古在秘魯當作食品使用,本發明 使用之其萃取物安全性無問題。故本發明提供之飲食品、香 粧品及醫藥品中馬卡萃取物之配合量,乃考慮其效果、添加 -9- 200529864 I 癱 時之製品之香味、色調等,可適宜決定其配合量。但配合範 圍乃將馬卡萃取物依乾燥重量換算,可001〜999%,宜001 〜99.5%之濃度範圍。 本發明提供之飲食品可爲糖果、舌片、口香糖、優格、 冰祺淋、布丁、軟糖、羊羹、酒精飲料、咖啡飲料、果汁、 果汁飮料、碳酸飮料、清涼飮料水、牛奶、乳清飮料、乳酸 菌飮料等等。 此等飮食品必要時可配合各種添加劑,依常法調製。具 ^體而言,調製此等飮食品時,將例如葡萄糖、果糖、蔗糖、 麥芽糖、山梨糖、斯替維苷、盧布索苷、玉米糖漿、乳糖、 檸檬酸、酒石酸、蘋果酸、丁二酸、乳酸、抗壞血酸、 d 1 -生育酣、異抗壞血酸鈉、甘油、丙二醇、甘油脂肪 酸酯、聚甘油脂肪酸酯、蔗糖脂肪酸酯、山梨糖脂肪酸酯、 丙一醇S曰肪酸酯、阿拉伯膠、鹿角菜膠、乾酪素、明膠、果 膠、洋菜、維生素Β類、菸鹼醯胺、泛酸鈣、胺基酸類、錦 鹽類、色素、香料、保存劑等可當作通常之食品原料使用者 鲁適宜地配合,依常法製造。 本發明提供之香粧品乃指稱爲化粧品及香料製品之製 品。可對例如化粧水、化粧霜、乳液、粉底、口紅、整髪料、 調髪料、育毛料、洗髮精、潤絲精、入浴劑等非口中用之香 粧品、牙膏類、洗口液、漱口藥、口腔香料等口中用之香粧 品含適量馬卡萃取物來調製目的之香粧品。 此等香粧品可將例如植物油等油脂類、羊毛脂及蜜蠟等 蠟類、烴類、脂肪酸、高級醇類、酯類、種種界面活性劑、 -10- 200529864 I 旛 色素、香料、維生素類、植物•動物萃取成分、紫外線吸收 劑、抗氧化劑、防腐·殺菌劑等通常之當作香粧品原料使用 者適宜地配合,依常法製得。 調製本發明提供之醫藥品時’必要時配合各種添加劑, 更適量含有馬卡萃取物,則可調製各種劑形之醫藥品。例如 以錠劑、膠囊劑、顆粒劑、散劑、糖漿劑、酏劑等經口醫藥 品,或以軟膏、眼軟膏、洗劑、霜劑、貼附劑、坐劑、點眼 藥、點鼻藥、注射劑等非經口醫藥品來提供。 ® 此等醫藥品可用各種添加劑依常法製造。使用之添加劑 無特限,可用通常使用者,例如澱粉、乳糖、白糖、甘露糖 醇、羧甲基纖維素、玉米澱粉、無機鹽等固形載體;蒸餾水、 生理食鹽水、葡萄糖水溶液、乙醇等醇、丙二醇、聚乙二醇 等液體載體;各種動植物油、白色凡士林、石蠟、蠟類等油 性載體等’。 本發明提供之馬卡萃取物不只有抗過敏作用,且經□服 用時之安全性也優異,故可適用爲飮食品、經口醫藥品、口 β中用之香粧品。 馬卡萃取物之每日之使用量及投與量無特限,例如依乾 燥重量換算可爲0.01m g〜10 g,若特爲經口期待顯著之抗 過敏作用時,例如依乾燥重量換算宜1 m g〜1 〇〇〇m g。 用本發明提供之馬卡萃取物調製飮食品、香粧品或醫藥 品時,可與其他抗炎症•抗過敏性之香粧品原料,例如石花 菜萃取成分(尤其甘草酸)、鹽酸苯海拉敏、葜、d ΐ-α-生育酚及其衍生物、維生素Β 2及Β 6等倂用。 -11- 200529864 本發明所謂飮食品用、香粧品用或醫藥品用之添加劑或 配合劑乃指在香料、色素、抗氧化劑等當作飮食品、香粧品 或醫藥品用通常使用之添加劑或配合劑混合馬卡萃取物 者。其混合比率可依目的而適宜地設定。在此所用之飮食 品、香粧品或醫藥品用之添加劑或配合劑可爲上述各種添加 劑。 【試驗方法】 本發明提供之馬卡萃取物之抗過敏作用可以抑制從肥 0 滿細胞游離組織胺之作用爲指標來評價。 其具體試驗方法如下。 從肥滿細胞之組織胺游離抑制作用 仿平井裕子等之方法(生藥學雜誌,37卷,374-380, 1 983 )。即,在脫血致死之Wistar系老鼠之腹腔內注入泰 洛(Tyro de )液來採集之腹腔細胞,依使用牛血清蛋白素 (BSA )-生理食鹽水(比重:1.068 )之重層離心法單離肥 滿細胞。所得細胞呈2xl〇6個/ m L懸浮在含有0· 1% BSA • 之泰洛液,來調製細胞浮游液。在試料溶液1 0μ L加細胞浮 游液1 〇μ L而在3 7 °C放置1 〇分後,加當作脫顆粒誘發劑之 化合物 48/80(5pg/mL )20μί,在 37°C 反應 10 分後, 一旦冰冷卻,將在離心分離(1 5 0 g X 5分)之上清中游離之 組織胺量以附螢光檢出器之高速液體層析來測定。 組織胺游離抑制活性乃依下式算出。 組織胺游離抑制率(% ) = 1 〇〇 X [ 1 _ ( S R C ) / ( R - C )] 其中, -12- 200529864 C :從對照之細胞游離之組織胺量 R :加誘發劑時從細胞游離之組織胺量 S R :將試料共存而加誘發劑時從細胞游離之組織胺 量。 【實施方式】 【實施例】 以下舉實施例更詳細説明本發明。 實施例1 :各種馬卡萃取物之製造 ©首先檢討馬卡之萃取條件(萃取溫度、乙醇濃度)對所 得馬卡萃取物之抗過敏作用之影響。 將馬卡10 g投入300m L之三角瓶,加如下表1所示各 種乙醇濃度之水溶液100m L,在表1所示溫度條件萃取3 小時。其中發明品1〇及發明品1 1乃將馬卡預先在50°C水萃 取1小時,使用其殘渣之馬卡。 將以上所得之萃取液過濾,使濾液凍乾,得本發明品1 〜4。將所得各發明品作成〇. 2 5 m g / m L溶液,評價由上 ® 述肥滿細胞之組織胺游離抑制作用。 另就除改變萃取條件(萃取溫度、乙醇濃度)以外均與 發明品同樣之操作所得對象品1〜4,評價由上述肥滿細胞之 組織胺游離抑制作用。 其結果如表1。 -13- 200529864 【表1】 萃取溫度 ΓΟ 萃取溶劑之乙醇濃度 (容量%) 組織胺游離抑制活性 (%) 對照品1 50 0 0 對照品2 90 0 0 對照品3 60 16 7 發明品1 60 30 18 發祖品2 60 45 70 發明品3 60 60 76 發明品4 60 95 83 發明品5 60 100 78 發明品6 40 60 56 發明品7 75 20 29 發明品8 25 100 31 發明品9 20 60 16 ―一蠢明品10 20 99 20 發明品11 60 99 81
由上述表中所示之結果得知,令萃取溶劑之乙醇濃度爲 20〜100%,萃取溫度爲20〜75 °C之範圍所得發明品1〜9 之組織胺游離抑制作用,與對照品1〜3比較皆強。另預先 將馬卡以水萃取處理所得馬卡殘渣爲原料之發明品1 0及1 1 也同。 尤其令萃取溶液之萃取溫度爲60°C、乙醇濃度爲45〜 100%所得發明品2〜5,及令萃取溶劑之萃取溫度爲40°C、 乙醇濃度爲60%所得發明品6,其組織胺之游離抑制活性爲 56〜83%,呈強大抗過敏作用。此與以同試驗系評價之DSCG (0.1m g / m L )之組織胺游離抑制作用(50% )比較也 強大。 由以上得知,以萃取溶劑爲比較高溫,且乙醇濃度高之 萃取溶劑萃取馬卡,則得抗過敏活性高之馬卡萃取物。 -14- 200529864 此等馬卡萃取物因具有非常強之抗過敏作用,且用 溶劑有安全性之乙醇水溶液,故所得馬卡萃取物可當作 品、經口醫藥品、口中用之香粧品。 製造例1 :含有馬卡萃取物之醫藥品 錠劑: 以如下示方法,製造含有馬卡萃取物之醫藥品(錠 將馬卡之乾燥粉碎物3 k g投入不鏽鋼容器,添力口 濃度爲99容量%之水溶液30 L,在60°C攪拌3小時。 φ 溶液,由所得萃取液除去溶劑,得1 80 g馬卡萃取物。 將此馬卡萃取物66.7g與乳糖232.0 g及硬脂酸I g混合,以單發式打錠機打錠,則得直徑10m m、重i m g之錠劑。 顆粒劑: 在仿上述製造例之方法所得之馬卡萃取物99.5 g 脂酸鎂〇·5 g,予以壓縮、粉碎、整粒、篩別而得20〜 之顆粒劑。 製浩例2 :含有馬卡萃取物之各種飲食物 ^ 以如下組成製造含馬卡萃取物之各種飮食品。 被田 · 糖釆· (組成) 粉末山梨糖 香料 馬卡萃取物 山製糖苷__ 全量 萃取 飮食 m ) 〇 丨乙醇 濾集 6 1.3 I 300 加硬 5〇篩 (重量份) 99.7 0.2 0.05 0.05 100.00 -15- 200529864
糖果= (組成) (重量份) 砂糖 47.0 麥芽糖 49.76 香料 1.0 水 2.0 馬卡萃取物 0.24 全量 100.00 舌片= (組成) (重量份) 阿拉伯膠 6.0 葡萄糖 73.0 馬卡萃取物 0.05 磷酸氫二鉀 0.2 磷酸二氫鉀 0.1 乳糖 17.0 香料 0.1 硬脂酸鎂 3.55 全量 100.00 口香糖: (組成) (重量份) 口香糖底膠 20.0 -16- 200529864
碳酸鈣 2.0 斯替維苷 0.1 馬卡萃取物 0.05 乳糖 76.85 香料 1.0 全量 100.00 牛奶糖: (組成) (重量份) 晶粒砂糖 32.0 麥芽糖 20.0 奶粉 40.0 硬化油 4.0 食鹽 0.6 香料 0.02 水 3.22 馬卡萃取物 0.16 全量 100.00 軟糖(咖啡軟糖) : (組成) (重量份) 晶粒砂糖 15.0 明膠 1.0 咖啡酏 5.0 -17- 200529864
水 78.93 馬卡萃取物 0.07 全量 100.00 冰淇淋: (組成) (重量份 生奶油(45%脂肪) 33.8 脫脂奶粉 1 1.0 晶粒砂糖 14.8 加糖蛋黄 0.3 香草精 0.1 水 39.93 馬卡萃取物 0.07 全量 100.00 布丁 : (組成) (重量份) 牛奶 47.5 1 全蛋 3 1.9 上白糖 17.1 水 3.4 馬卡萃取物 0.09 全量 100.00 200529864
羊羹: (組成) (重量份) 紅豆饀 24.8 粉末洋菜 0.3 食鹽 0.1 上白糖 24.9 馬卡萃取物 0.1 7k 49.8 全量 100.0 果汁: (組成) (重量份) 冷凍濃縮溫州桔果汁 5.0 果糖葡萄糖液糖 11.0 檸檬酸 0.2 L -抗壞血酸 0.02 馬卡萃取物 0.05 香料 0.2 色素 0.1 7k 83.43 全量 100.00 碳酸飮料: (組成) (重量份) -19- 200529864 晶粒砂糖 8.0 濃縮檸檬果汁 1.0 L -抗壞血酸 0.10 檸檬酸 0.09 檸檬酸鈉 0.05 著色料 0.05 香料 0.15 碳酸水 90.55 馬卡茺取物 0.01 全量 100.00 乳酸菌飲料= (組成) (重量份) 乳固形分21%發酵乳 14.76 果糖葡萄糖液糖 13.3 1 果膠 0.5 檸檬酸 0.08 香料 0.15 水 7 1.14 馬卡萃取物 0.06 全量 100.00 咖啡飮料: (組成) (重量份) -20- 200529864
晶粒砂糖 8.0 脫脂奶粉 5.0 焦糖 0.2 咖啡萃取物 2.0 香料 0.1 聚甘油脂肪酸酯 0.05 食鹽 0.05 水 84.56 馬卡萃取物 0.04 全量 100.00 酒精飮料: (組成) (重量份) 50容量%乙醇 32.0 砂糖 8.4 果汁 2.4 馬卡萃取物 0.2 精製水 57.0 全量 100.0 製浩例3 :含有馬卡萃取物之各種香粧品 以如下組成製造含馬卡萃取物之各種香粧品。 牙膏劑: (組成) (重量份) -2 1- 200529864 «
磷酸氫二鈣 42.0 甘油 18.0 鹿角菜膠 0.9 十二基硫酸鈉 1.2 糖精鈉 0.09 對羥苯甲酸丁酯 0.005 馬卡萃取物 0.05 香料 1.0 7k 36.755 全量 100.00 洗口液: (組成) (重量份) 十二基硫酸鈉 0.8 甘油 7.0 山梨糖 5.0 乙醇 15.0 馬卡萃取物 0.05 1 -薄荷腦 0.05 香料 0.04 糖精鈉 0.1 7k 7 1.96 全量 100.00 -22- 200529864 柔軟香粧品(弱酸性): (組成) (重量份) 甘油 5.0 丙二醇 4.0 透明質酸鈉 0.1 馬卡萃取物 0.05 聚氧乙烯山梨糖單十二酸酯(20EO) 1.5 聚氧乙烯十二基醚(20EO) 0.5 # 乙醇 〇.〇 香料 0.1 染料 微量 防腐劑微量 微量 紫外線吸收劑微量 微量 精製 7k_78.75 全量 100.00
保濕霜: (組成) (重量份) 蜜鱲 2.0 硬脂醇 5.0 硬脂酸 8.0 角鯊烷 10.0 自己乳化型丙二醇單硬脂酸酯 3.0 聚氧乙烯十六醚(20E〇) 1.0 -23- 200529864 j 0.5 微量 微量 4.8 3.0 0.1 0.1 1.0 6 1.5 100.0 香料 抗氧化劑 防腐劑 丙二醇 甘油 透明質酸鈉 馬卡萃取物 三乙醇胺 , 精製7k 全量 保濕洗劑= (組成) 硬脂酸 十六醇 凡士林 羊毛脂醇 液態石鱲 聚氧乙烯單油酸酯( 香料 抗氧化劑 防腐劑 丙二醇 甘油 (重量份) 2.0 1.5 3.0 2.0 10.0 10 E 〇) 2.0 0.5 微量 微量 4.8 3.0 -24- 200529864
透明質酸鈉 馬卡萃取物 三乙醇胺 精製水 0.1 0.1 1.0 70.0 全量 100.0 乳液狀粉底: (組成) (重量份 硬脂酸 2.4 單硬脂酸丙二醇 2.0 十六基硬脂醇 0.2 液狀羊毛脂 2.0 液態石鱲 3.0 十四酸異丙酯 8.5 對羥苯甲酸丙酯 微量 精製水 64.1 羧甲基纖維素鈉 0.2 膨土 0.5 丙二醇 3.8 透明質酸鈉 0.1 馬卡萃取物 0.1 三乙醇胺 1. 1 對羥苯甲酸甲酯 微量 氧化鈦 8.0 -25- 200529864
滑石 著色含量 香料微量 4.0 微量 全量 100.0 育毛調髪料= (組成) (重量份) 乙醇 70.0 十藥酏 0.2 維生素E 0.2 1 -薄荷腦 0.4 甘草酸 0.1 馬卡萃取物 0.1 水楊酸 0.5 甘油 0.5 香料 微量 精製水 28.0 全量 100.0 洗髮精: (組成) (重量份) 院基醚硫酸納 16.0 十二酸二乙醇胺 4.0 丙二醇 1.9 -26- 200529864 馬卡萃取物 防腐劑 色素 香料 精製7k 0.1 微量 微量 微量 78.0 全量 100.0 潤絲精: (組成) (重量份) 氯化硬脂二甲基 1.4 苄銨硬脂醇 0.6 甘油單硬脂酸酯 1.5 食鹽 0.1 馬卡萃取物 0.1 精製7k 96.3 全量 100.0 【産業上之利用可能性】 如上所述,依本發明之萃取方法可提供具有強力抗過敏 作用之馬卡萃取物。所得馬卡萃取物具有強力抗過敏活性, 故含有它之飮食品、香粧品或醫藥品對過敏疾病患者極爲有 效,在日常生活可抑制過敏症狀之發現,故其産業上之貢獻 度頗大。 【圖式簡單說明】 4τγγ. 撕0 -27-
Claims (1)
- 200529864 十、申請專利範圍: 1 . 一種馬卡萃取物之萃取方法,其係在馬卡之粉碎物加含有 乙醇之水溶液來萃取馬卡萃取物之萃取方法,其特徵爲萃 取液之溫度爲2 0〜7 5 t。 2 ·如申請專利範圍第1項之萃取方法,其中含有乙醇之水溶 液中乙醇之濃度爲20〜100容量%。 3 .如申請專利範圍第1項之萃取方法,其中對馬卡之粉碎物 1重量份使用含有乙醇之水溶液0.3〜500重量份。 • 4·如申請專利範圍第1〜3項中任一項之萃取方法,其中馬 卡之粉碎物爲水萃取殘渣。 5 · —種馬卡萃取物,其係得自如申請專利範圍第1〜4項中 任一項之萃取方法。 6 · —種飮食品、香粧品或醫藥品,其係含如申請專利範圔第 5項之馬卡萃取物。 7 .如申請專利範圍第6項之飮食品、香粧品或醫藥品,其中 如申請專利範圍第5項之馬卡萃取物依乾燥重量換算含 鲁 有 0.01 〜99.5%。 8 ·如申請專利範圍第6或7項之飮食品、香粧品或醫藥品, 其係具有抗過敏作用。 9· 一種飮食品用、香粧品用或醫藥品用之添加劑或配合劑, 其特徵爲含有如申請專利範圍第5項之馬卡萃取物。 1 〇·如申請專利範圍第8項之飮食品、香粧品或醫藥品,其係 糖果、舌片、口香糖、顆粒或錠劑。 -28- 200529864 Μ 、 七、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明: 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式: 無0
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004019283 | 2004-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200529864A true TW200529864A (en) | 2005-09-16 |
Family
ID=34823710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094102402A TW200529864A (en) | 2004-01-28 | 2005-01-27 | Method for producing maca extract |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070280975A1 (zh) |
EP (1) | EP1714635A1 (zh) |
JP (1) | JPWO2005072684A1 (zh) |
KR (1) | KR20060128964A (zh) |
CN (1) | CN1909881A (zh) |
AU (1) | AU2005207718A1 (zh) |
CA (1) | CA2553987A1 (zh) |
TW (1) | TW200529864A (zh) |
WO (1) | WO2005072684A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI383754B (zh) * | 2008-07-18 | 2013-02-01 | Tci Co Ltd | 食品錠劑 |
CN111093619A (zh) * | 2018-08-02 | 2020-05-01 | 安帝芭株式会社 | 男性清洁剂及其制备方法 |
TWI874771B (zh) * | 2021-05-31 | 2025-03-01 | 高雄醫學大學 | 馬卡萃取物及其用途 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006204210A (ja) * | 2005-01-28 | 2006-08-10 | Towa Corporation 株式会社 | ベンジルグルコシノレート含有組成物、その呈味改善方法およびベンジルグルコシノレート含有飲料物 |
JP4627477B2 (ja) * | 2005-10-07 | 2011-02-09 | サントリーホールディングス株式会社 | 酢酸又は食酢を配合したマカ抽出物含有飲食物 |
JP5064714B2 (ja) * | 2006-04-21 | 2012-10-31 | 日本メナード化粧品株式会社 | 抗ストレス組成物 |
KR100814133B1 (ko) | 2006-12-05 | 2008-03-18 | 주식회사 내추럴하우스 | 마카마이드 고 함유 마카 추출물 제조방법 |
KR101017315B1 (ko) * | 2007-07-18 | 2011-02-28 | 주식회사 이스터비엔에프 | 발효 마카 조성물 및 그 제조 방법 |
KR101320374B1 (ko) * | 2009-08-11 | 2013-10-23 | 김연진 | 치아 시드 및 마카를 포함하는 건강보조식품, 사료, 약학 조성물 및 그 제조방법 |
CA2772213A1 (en) * | 2009-09-04 | 2011-03-10 | Thomas Szoke | A personalized multifunctional access device possessing an individualized form of authenticating and controlling data exchange |
CN101816365A (zh) * | 2010-04-30 | 2010-09-01 | 云南瑞升烟草技术(集团)有限公司 | 一种玛咖糖果 |
ITVA20100074A1 (it) * | 2010-10-11 | 2012-04-12 | Cinzia Maiuri | Composizione cosmeceutica riepitelizzante, anti-aging, antiossidante, antiradicali liberi e/o igienizzante dell' apparato buccale. |
FR2969495B1 (fr) * | 2010-12-22 | 2013-10-11 | Expanscience Lab | Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant |
CN102579547A (zh) * | 2012-03-26 | 2012-07-18 | 张丽琴 | 玛咖有效成分的提取方法 |
CN102551066A (zh) * | 2012-03-26 | 2012-07-11 | 张丽琴 | 玛咖虫草松露保健食品 |
CN102697039A (zh) * | 2012-05-31 | 2012-10-03 | 昆明理工大学 | 一种玛卡活性萃取物的制备方法 |
CN104513173B (zh) * | 2013-09-30 | 2018-03-06 | 中国科学院过程工程研究所 | 一种玛咖提取物、其制备方法及其用途 |
CN104146250B (zh) * | 2014-08-02 | 2016-01-20 | 昆明骊玛生物科技有限公司 | 一种玛咖组合物的制备方法及其应用 |
CN104207134B (zh) * | 2014-10-11 | 2016-05-11 | 王衍彬 | 一种玛咖提取物的制备方法 |
WO2017155515A1 (en) * | 2016-03-08 | 2017-09-14 | MANSOUR, Mariam, Awadh | Herbal sonicated e-nano e-liquid mix for zero-nicotine e-cigarette for improving smoker's health |
KR101785348B1 (ko) | 2016-05-25 | 2017-10-17 | 남광섭 | 흑마늘과 흑마카 혼합 추출엑기스의 제조방법 |
US20180085303A1 (en) * | 2016-09-23 | 2018-03-29 | Smoothie Beauty, Inc. | Cosmetic compositions comprising food-grade components and methods of making and using same |
CN111083923A (zh) * | 2018-08-20 | 2020-04-28 | 安帝芭株式会社 | 舒缓霜以及其制造方法 |
JP7672965B2 (ja) * | 2021-12-24 | 2025-05-08 | カゴメ株式会社 | グルコシノレート含有組成物の製造方法、及びグルコシノレート含有植物からのグルコシノレートの抽出効率を高める方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0812565A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | 皮膚外用剤 |
US6267995B1 (en) * | 1999-03-03 | 2001-07-31 | Pure World Botanicals, Inc. | Extract of Lepidium meyenii roots for pharmaceutical applications |
JP2001039854A (ja) * | 1999-07-30 | 2001-02-13 | Sanko Bussan Kk | 皮膚外用剤 |
JP2002161043A (ja) * | 2000-11-27 | 2002-06-04 | Ts Aasu:Kk | 皮膚外用剤 |
JP2004000171A (ja) * | 2002-03-22 | 2004-01-08 | Towa Corp | マカを含有した機能性食品 |
-
2005
- 2005-01-27 TW TW094102402A patent/TW200529864A/zh unknown
- 2005-01-28 KR KR1020067015187A patent/KR20060128964A/ko not_active Withdrawn
- 2005-01-28 EP EP05709428A patent/EP1714635A1/en not_active Withdrawn
- 2005-01-28 AU AU2005207718A patent/AU2005207718A1/en not_active Abandoned
- 2005-01-28 WO PCT/JP2005/001201 patent/WO2005072684A1/ja active Application Filing
- 2005-01-28 CN CNA200580002835XA patent/CN1909881A/zh active Pending
- 2005-01-28 JP JP2005517506A patent/JPWO2005072684A1/ja active Pending
- 2005-01-28 CA CA002553987A patent/CA2553987A1/en not_active Abandoned
- 2005-01-28 US US10/587,522 patent/US20070280975A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI383754B (zh) * | 2008-07-18 | 2013-02-01 | Tci Co Ltd | 食品錠劑 |
CN111093619A (zh) * | 2018-08-02 | 2020-05-01 | 安帝芭株式会社 | 男性清洁剂及其制备方法 |
TWI874771B (zh) * | 2021-05-31 | 2025-03-01 | 高雄醫學大學 | 馬卡萃取物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2005072684A1 (ja) | 2005-08-11 |
US20070280975A1 (en) | 2007-12-06 |
CA2553987A1 (en) | 2005-08-11 |
JPWO2005072684A1 (ja) | 2007-09-06 |
AU2005207718A1 (en) | 2005-08-11 |
KR20060128964A (ko) | 2006-12-14 |
CN1909881A (zh) | 2007-02-07 |
EP1714635A1 (en) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200529864A (en) | Method for producing maca extract | |
JP2009126863A (ja) | キノコから抽出したエルゴチオネインを高含有する組成物 | |
JP6714928B2 (ja) | コラゲナーゼ阻害剤 | |
CN108697685A (zh) | 含有桑辛素、桑黄铜g或桑白皮的,肌肉疾病的预防及治疗用或肌功能改善用组合物 | |
US20090269424A1 (en) | Peripheral blood flow-improving composition | |
JP2002293736A (ja) | メーラード反応阻害剤およびそれを含有する組成物 | |
KR20150087724A (ko) | 개똥쑥 추출물을 유효성분으로 포함하는 항산화용 조성물 | |
KR101820531B1 (ko) | 니파야자 꽃대를 이용한 탈모방지 또는 발모촉진용 조성물 | |
JP6902329B2 (ja) | 皮脂腺細胞の活性化の抑制剤 | |
KR102137136B1 (ko) | 호박 가수분해 추출물, 구약감자 가수분해 추출물, 강황 추출물 및 카카오닙스 추출물을 포함하는 조성물 | |
KR101935492B1 (ko) | 야라야라를 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
JP5403320B2 (ja) | 天然抽出物より得られた脱顆粒抑制剤、β−ヘキソサミニダーゼ遊離抑制剤、抗アレルギー剤および抗炎症剤 | |
CN106999528A (zh) | 用于预防掉发或刺激头发生长的包含高山黄芩萃取物的组合物 | |
WO2005094859A1 (ja) | 皮膚保湿能改善剤 | |
KR102465346B1 (ko) | 구절초 및 꾸지뽕 복합 추출물을 유효성분으로 포함하는 항염증 조성물 | |
JP2007084535A (ja) | ワサビを有効成分とする脂肪蓄積抑制用組成物 | |
JP5582593B2 (ja) | 血小板凝集抑制剤 | |
JPH09315987A (ja) | 泡盛の抗アレルギー有効成分としての利用 | |
JP2006233099A (ja) | 褐藻類盤状体由来フコイダン多糖およびその利用 | |
JP7300121B2 (ja) | 抗糖化用組成物、及び抗糖化用組成物の製造方法 | |
JP7320270B2 (ja) | 肝機能改善剤 | |
JP2010208953A (ja) | リパーゼ阻害剤 | |
JP2008280320A (ja) | エストロゲン様作用剤 | |
JP2025072344A (ja) | オートファジー誘導剤 | |
JP5783404B2 (ja) | ヒアルロニダーゼ阻害剤 |